Robeco Institutional Asset Management B.V. Has $44.33 Million Position in Amdocs Limited (NASDAQ:DOX)

Robeco Institutional Asset Management B.V. lowered its holdings in Amdocs Limited (NASDAQ:DOX) by 1.6% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 520,709 shares of the technology company’s stock after selling 8,615 shares during the period. Robeco Institutional Asset Management B.V. owned approximately 0.46% of Amdocs worth $44,333,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also modified their holdings of the company. Allspring Global Investments Holdings LLC lifted its stake in Amdocs by 36.6% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 3,175,790 shares of the technology company’s stock worth $277,818,000 after acquiring an additional 851,022 shares in the last quarter. Pzena Investment Management LLC boosted its holdings in shares of Amdocs by 12.3% during the third quarter. Pzena Investment Management LLC now owns 6,363,739 shares of the technology company’s stock worth $556,700,000 after purchasing an additional 696,136 shares during the period. Hotchkis & Wiley Capital Management LLC grew its position in Amdocs by 123.2% during the third quarter. Hotchkis & Wiley Capital Management LLC now owns 759,136 shares of the technology company’s stock valued at $66,409,000 after purchasing an additional 419,045 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its stake in Amdocs by 1,207.3% in the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 271,701 shares of the technology company’s stock valued at $23,768,000 after buying an additional 250,918 shares during the period. Finally, Geode Capital Management LLC lifted its position in Amdocs by 10.8% in the 3rd quarter. Geode Capital Management LLC now owns 1,633,733 shares of the technology company’s stock worth $143,498,000 after buying an additional 158,843 shares in the last quarter. Hedge funds and other institutional investors own 92.02% of the company’s stock.

Amdocs Stock Performance

Shares of NASDAQ DOX opened at $86.31 on Thursday. The business’s 50-day simple moving average is $85.82 and its 200-day simple moving average is $86.25. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.20 and a current ratio of 1.20. Amdocs Limited has a 52 week low of $74.41 and a 52 week high of $94.04. The firm has a market cap of $9.74 billion, a price-to-earnings ratio of 20.36, a P/E/G ratio of 1.42 and a beta of 0.71.

Amdocs Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, January 31st. Stockholders of record on Tuesday, December 31st will be given a $0.479 dividend. This represents a $1.92 dividend on an annualized basis and a dividend yield of 2.22%. The ex-dividend date of this dividend is Tuesday, December 31st. Amdocs’s dividend payout ratio is 45.28%.

Analyst Ratings Changes

Several equities analysts have recently commented on the stock. Oppenheimer boosted their price target on shares of Amdocs from $98.00 to $105.00 and gave the company an “outperform” rating in a report on Wednesday, November 13th. StockNews.com downgraded Amdocs from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, January 14th. Stifel Nicolaus started coverage on Amdocs in a report on Wednesday, October 2nd. They set a “buy” rating and a $100.00 price target for the company. Finally, Barclays dropped their price objective on Amdocs from $113.00 to $111.00 and set an “overweight” rating on the stock in a report on Thursday, November 14th. One equities research analyst has rated the stock with a hold rating and five have issued a buy rating to the company. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $101.20.

Amdocs Company Profile

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.